Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sequenom's MaterniT21 Plus; Milford Medical Lab's Lyme Disease Test

Premium

The Mayo Medical Laboratories will now offer Sequenom's MaterniT21 Plus test to patients at high risk for fetal chromosome abnormalities. The test uses next-generation sequencing to noninvasively screen for fetal aneuploidies in chromosomes 21, 18, and 13, as well as the X and Y chromosomes. It also reports some subchromosomal microdeletions and microduplications.


Milford Medical Laboratory in Connecticut is now offering a Sanger sequencing-based test for Borrelia burgdorferi and Borrelia miyamotoi, which cause Lyme disease and Lyme disease-like infection. The test sequences a target segment of the bacterial16S ribosomal RNA gene and is available for $150.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.